These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 18395014)

  • 1. Quadruplex DNA crystal structures and drug design.
    Neidle S; Parkinson GN
    Biochimie; 2008 Aug; 90(8):1184-96. PubMed ID: 18395014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NMR-Based model of a telomerase-inhibiting compound bound to G-quadruplex DNA.
    Fedoroff OY; Salazar M; Han H; Chemeris VV; Kerwin SM; Hurley LH
    Biochemistry; 1998 Sep; 37(36):12367-74. PubMed ID: 9730808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topology conservation and loop flexibility in quadruplex-drug recognition: crystal structures of inter- and intramolecular telomeric DNA quadruplex-drug complexes.
    Parkinson GN; Cuenca F; Neidle S
    J Mol Biol; 2008 Sep; 381(5):1145-56. PubMed ID: 18619463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-based design of selective and potent G quadruplex-mediated telomerase inhibitors.
    Read M; Harrison RJ; Romagnoli B; Tanious FA; Gowan SH; Reszka AP; Wilson WD; Kelland LR; Neidle S
    Proc Natl Acad Sci U S A; 2001 Apr; 98(9):4844-9. PubMed ID: 11309493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [G-quadruplex DNA: myth or reality?].
    Riou JF; Gomez D; Lemarteleur T; Trentesaux C
    Bull Cancer; 2003 Apr; 90(4):305-13. PubMed ID: 12801813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A chiral wedge molecule inhibits telomerase activity.
    Shinohara K; Sannohe Y; Kaieda S; Tanaka K; Osuga H; Tahara H; Xu Y; Kawase T; Bando T; Sugiyama H
    J Am Chem Soc; 2010 Mar; 132(11):3778-82. PubMed ID: 20192187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective interactions of perylene derivatives having different side chains with inter- and intramolecular G-quadruplex DNA structures. A correlation with telomerase inhibition.
    Rossetti L; Franceschin M; Schirripa S; Bianco A; Ortaggi G; Savino M
    Bioorg Med Chem Lett; 2005 Jan; 15(2):413-20. PubMed ID: 15603964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The recognition of higher-order G-quadruplex by chiral cyclic-helicene molecules.
    Xu Y; Yamazaki S; Osuga H; Sugiyama H
    Nucleic Acids Symp Ser (Oxf); 2006; (50):183-4. PubMed ID: 17150878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isaindigotone derivatives: a new class of highly selective ligands for telomeric G-quadruplex DNA.
    Tan JH; Ou TM; Hou JQ; Lu YJ; Huang SL; Luo HB; Wu JY; Huang ZS; Wong KY; Gu LQ
    J Med Chem; 2009 May; 52(9):2825-35. PubMed ID: 19354252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystallographic studies of quadruplex nucleic acids.
    Campbell NH; Parkinson GN
    Methods; 2007 Dec; 43(4):252-63. PubMed ID: 17967696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conformational studies and solvent-accessible surface area analysis of known selective DNA G-Quadruplex binders.
    Alcaro S; Artese A; Costa G; Distinto S; Ortuso F; Parrotta L
    Biochimie; 2011 Aug; 93(8):1267-74. PubMed ID: 21699954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of telomerase inhibitors based on g-quadruplex ligands by a modified telomeric repeat amplification protocol assay.
    Gomez D; Mergny JL; Riou JF
    Cancer Res; 2002 Jun; 62(12):3365-8. PubMed ID: 12067975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selectivity of small molecule ligands for parallel and anti-parallel DNA G-quadruplex structures.
    Garner TP; Williams HE; Gluszyk KI; Roe S; Oldham NJ; Stevens MF; Moses JE; Searle MS
    Org Biomol Chem; 2009 Oct; 7(20):4194-200. PubMed ID: 19795057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phenol quaternary ammonium porphyrin as a potent telomerase inhibitor by selective interaction with quadruplex DNA.
    Wang P; Ren L; He H; Liang F; Zhou X; Tan Z
    Chembiochem; 2006 Aug; 7(8):1155-9. PubMed ID: 16810656
    [No Abstract]   [Full Text] [Related]  

  • 15. Affinity and selectivity of G4 ligands measured by FRET.
    De Cian A; Guittat L; Shin-ya K; Riou JF; Mergny JL
    Nucleic Acids Symp Ser (Oxf); 2005; (49):235-6. PubMed ID: 17150720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-based design of benzylamino-acridine compounds as G-quadruplex DNA telomere targeting agents.
    Martins C; Gunaratnam M; Stuart J; Makwana V; Greciano O; Reszka AP; Kelland LR; Neidle S
    Bioorg Med Chem Lett; 2007 Apr; 17(8):2293-8. PubMed ID: 17276687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural basis of telomeric RNA quadruplex--acridine ligand recognition.
    Collie GW; Sparapani S; Parkinson GN; Neidle S
    J Am Chem Soc; 2011 Mar; 133(8):2721-8. PubMed ID: 21291211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting telomeres and telomerase.
    De Cian A; Lacroix L; Douarre C; Temime-Smaali N; Trentesaux C; Riou JF; Mergny JL
    Biochimie; 2008 Jan; 90(1):131-55. PubMed ID: 17822826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural investigations of acridine derivatives by CoMFA and CoMSIA reveal novel insight into their structures toward DNA G-quadruplex mediated telomerase inhibition and offer a highly predictive 3D-model for substituted acridines.
    Zambre VP; Murumkar PR; Giridhar R; Yadav MR
    J Chem Inf Model; 2009 May; 49(5):1298-311. PubMed ID: 19413274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 6-mer photocontrolled oligonucleotide as an effective telomerase inhibitor.
    Xu Y; Ito K; Suzuki Y; Komiyama M
    J Am Chem Soc; 2010 Jan; 132(2):631-7. PubMed ID: 20014834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.